Clinical Trial Update: Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SCT800 in previously treated paediatric patients with severe Hemophilia A, assessing safety, efficacy and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• SCT800

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Hemophilia A | Phase 3 | Status: UNKNOWN